Literature DB >> 16929810

The declaration of Helsinki 2000: ethical principles and the dignity of difference.

S E Salako1.   

Abstract

The first detailed regulations about nontherapeutic research were promulgated by the Prussian Government in 1900. In 1947, the Nuremberg Code was decreed. Since then, the Declaration of Helsinki (DOH) was adopted in 1964 and has been revised five times. The object of this article is to evaluate the 2000 Revision of the DOH and discuss three problems of concern. These problems are: (1) If, unlike its predecessors, the DOH (2000) has recast itself as a minimum set of international standards 'binding' on physicians worldwide, from where does it derive its authority? (2) The wording of the DOH is incongruent with the underlying ethical principles. (3) The projection of the DOH into the realms of social justice raises the issue of human dignity. Finally, the feasibility or desirability of a theory of justice privileging human dignity as one of its guiding principles and the future of the DOH are examined.

Entities:  

Mesh:

Year:  2006        PMID: 16929810

Source DB:  PubMed          Journal:  Med Law        ISSN: 0723-1393


  28 in total

1.  Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.

Authors:  A Mansour; M Nabil; R Ali-Labib; H Said; F Annos
Journal:  Med Oncol       Date:  2011-12-08       Impact factor: 3.064

2.  Using a laryngeal tube during cardiac arrest reduces "no flow time" in a manikin study: a comparison between laryngeal tube and endotracheal tube.

Authors:  Christoph H R Wiese; Utz Bartels; Anna Bergmann; Ingo Bergmann; Jan Bahr; Bernhard M Graf
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 3.  Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.

Authors:  DeRen Huang
Journal:  Neurosci Bull       Date:  2015-12       Impact factor: 5.203

4.  Online sonification for golf putting gesture: reduced variability of motor behaviour and perceptual judgement.

Authors:  Benjamin O'Brien; Brett Juhas; Marta Bieńkiewicz; Frank Buloup; Lionel Bringoux; Christophe Bourdin
Journal:  Exp Brain Res       Date:  2020-03-11       Impact factor: 1.972

5.  [Cancer pain therapy in palliative care patients: knowledge of prehospital emergency physicians in training. Prospective questionnaire-based investigation].

Authors:  C H R Wiese; E K Löffler; J Vormelker; N Meyer; M Taghavi; M Strumpf; S Kazmaier; M Roessler; Y A Zausig; A F Popov; C L Lassen; B M Graf; G G Hanekop
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

6.  Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects.

Authors:  Brigida Fierro; Filippo Brighina; Marco D'Amelio; Ornella Daniele; Innocenzo Lupo; Paolo Ragonese; Antonio Palermo; Giovanni Savettieri
Journal:  Exp Brain Res       Date:  2007-09-08       Impact factor: 1.972

7.  [Emergency outpatient palliative care in acute situations by paramedics].

Authors:  Christoph H R Wiese; Utz Bartels; David Ruppert; Hartwig Marung; Bernhard M Graf; Gerd G Hanekop
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  [Palliative care patients in an advanced state of disease. Cardiopulmonary resuscitation and determination of death].

Authors:  C H R Wiese; U Bartels; G Duttge; B M Graf; G G Hanekop
Journal:  Anaesthesist       Date:  2008-09       Impact factor: 1.041

9.  Prehospital emergency treatment of palliative care patients with cardiac arrest: a retrolective investigation.

Authors:  Christoph H R Wiese; Utz E Bartels; York A Zausig; Jochen Pfirstinger; Bernhard M Graf; Gerd G Hanekop
Journal:  Support Care Cancer       Date:  2009-10-08       Impact factor: 3.603

10.  Quality of out-of-hospital palliative emergency care depends on the expertise of the emergency medical team--a prospective multi-centre analysis.

Authors:  Christoph H R Wiese; Utz E Bartels; Karolina Marczynska; David Ruppert; Bernhard M Graf; Gerd G Hanekop
Journal:  Support Care Cancer       Date:  2009-03-25       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.